ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these medications may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication must evaluate the benefits of using it against the potential risks for the baby. Physicians don't have the data to provide clear recommendations however they can provide information about risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who took ADHD medications during early pregnancy did not have an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a vast population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure correct classification of the cases and to reduce the chance of bias.

The study of the researchers had some limitations. Most important, they were not able to differentiate the effects of the medication from the effects of the disorder at hand. That limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to the use of medication or confounding by comorbidities. The researchers did not study long-term outcomes best medicine for adhd and social anxiety the offspring.

The study did find that infants whose mothers took ADHD medication during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or taken off their medication prior to or during pregnancy. This was due to central nervous system disorders, and the higher risk of admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who took stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean section or having a child with a low Apgar score (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

The researchers suggest that the risk of a small amount with the use of adhd medication in uk medications during early pregnancy may be offset by the greater benefit for both mother and child of continued treatment for the woman's disorder. Physicians should speak with their patients about this issue and, if possible, help them develop coping strategies that may reduce the impact of her disorder in her daily life and relationships.

Interactions with Medication

As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether to continue or stop treatment during pregnancy is a question that doctors are having to have to face. Most of the time, these decisions are taken in the absence of clear and authoritative evidence regardless, so doctors must weigh what they know from their own experiences, those of other doctors, and what the research suggests about the subject, along with their own judgments for each patient.

In particular, the issue of possible risks to the baby can be a challenge. Many studies on this issue are based on observations rather than controlled research and their conclusions are often contradictory. Most studies limit their analysis to live births, which can underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study discussed in the journal club addresses these issues, by examining both information on deceased and live births.

Conclusion Some studies have shown a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. The majority of studies show an unintended, or somewhat negative, effect. In the end an accurate risk-benefit analysis must be conducted in every situation.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In an article recently published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation and family conflict for those suffering from the disorder. A decrease in medication could affect the ability to safely drive and to perform work-related tasks which are vital aspects of normal life for people with ADHD.

She recommends that women who are unsure about whether to continue or discontinue medication due to their pregnancy consider educating family members, friends and colleagues about the condition, its impact on daily functioning, and the advantages of staying on the current treatment plan. In addition, educating them can help the woman feel supported in her struggle with her decision. It is important to note that certain drugs can be absorbed through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware of the possibility that traces of the drug could be transferred to the infant.

Birth Defects Risk

As the use and misuse of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases, so does concern about the potential effects of these drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. With two massive data sets, researchers were able to analyze more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Although the risk overall remains low, the scientists found that exposure in the first trimester to ADHD medications was linked to a slightly higher rate of certain heart defects, like ventriculo-septal defects (VSD).

The researchers of the study found no link between early medication use and other congenital anomalies, like facial clefting, or club foot. The results are in agreement with previous studies which showed a small, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the time of pregnancy. The risk grew in the later part of pregnancy, as many women are forced to stop taking their ADHD medications.

Women who were taking ADHD medication during the first trimester were more likely to need a caesarean and also have an insufficient Apgar after delivery and have a baby who needed help breathing at birth. The researchers of the study could not eliminate bias due to selection because they limited the study to women with no other medical conditions that might have contributed to the findings.

The researchers hope their research will help inform the clinical decisions of physicians who see pregnant women. The researchers advise that while discussing benefits and risks are important, the decision on whether to continue or stop taking medication should be based on the severity of each woman's ADHD symptoms and her requirements.

The authors caution that, while stopping the medication is an option to consider, it is not recommended due to the high rate depression and mental health issues in women who are expecting or recently gave birth. Further, research shows that women who Prescribes medication for adhd stop taking their medications will have a harder transitioning to life without them after the baby is born.

Nursing

The responsibilities of a new mom can be overwhelming. Women with ADHD who have to deal with their symptoms while attending doctor appointments as well as making preparations for the arrival of a child and adjusting to new household routines may face a lot of challenges. As such, many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The risk for nursing infant is low because the majority of stimulant medication passes through breast milk at a low estrogen and adhd medication level. However, the amount of medication exposure to the newborn may differ based on dosage, how often it is administered, and the time of day it is administered. In addition, various drugs enter the infant's system via the gastrointestinal tract or breast milk. The impact of these medications on the health of a newborn is not fully understood.

Due to the absence of research, some doctors may recommend stopping stimulant medications during a woman's pregnancy. This is a complicated decision for the patient, who must weigh the benefit of continuing her medication against the potential dangers to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue to take their ADHD medication safely during pregnancy and while breast-feeding. In response, a rising number of patients are opting to do so. They have concluded, in consultation with their doctor that the benefits of retaining their current medication outweigh any risk.

Women with ADHD who are planning to nurse should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD recognize their symptoms and the root cause, learn about available treatment options and strengthen existing coping strategies. This should be a multidisciplinary process with the GPs, obstetricians and psychiatrists. Counselling for pregnancy should include discussion of a management plan for both mother and child, and monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.